论文信息 - O-0022RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF TAS-102 VS. PLACEBO, WITH BEST SUPPORTIVE CARE (BSC), IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) REFRACTORY TO STANDARD THERAPIES (RECOURSE) - 字舞流文

O-0022RESULTS OF A MULTICENTER, RANDOMIZED, DOUBLE-BLIND, PHASE III STUDY OF TAS-102 VS. PLACEBO, WITH BEST SUPPORTIVE CARE (BSC), IN PATIENTS (PTS) WITH METASTATIC COLORECTAL CANCER (MCRC) REFRACTORY TO STANDARD THERAPIES (RECOURSE)

Y. Shimada | Mamoru Ito | H. Lenz | J. Tabernero | B. Tran | R. Mayer | A. Ohtsu | A. Zaniboni | H. Hochster | A. Falcone | R. García-Carbonero | M. Aivado | T. Yoshino | A. Sobrero | E. Cutsem | M. Peeters | Y. Komatsu | K. Yamazaki | E. Boucher | N. Mizunuma | F. Benedetti | L. Makris